<\/p>\n
GLP-1 medication lingo and all the numbers that come with it can get confusing fast. And when learning about dosing feels like it requires cracking open a science textbook, that learning curve only gets steeper. If your head is spinning around the ins and outs of GLP-1 dosing\u2014or you\u2019re just looking to feel more confident about how it works\u2014you\u2019re in the right place. Ahead, we\u2019re breaking down everything you need to know with expert insight.<\/p>\n
GLP-1 dosing typically starts low to prevent tolerance issues and the often-talked-about side effects that affect \u201cdigestion, appetite signaling and gut motility,\u201d says New York endocrinologist Rocio Salas-Whalen, MD. \u201cStarting low allows the brain and gastrointestinal system to adapt, which helps minimize side effects like nausea, reflux or fatigue.\u201d This early phase of the GLP-1 process is known as titration, a carefully managed adjustment period. Once tolerated, the dose can be gradually increased\u2014or held\u2014under the supervision of your provider.<\/p>\n
Another reason, Portage, MI lipid and obesity specialist Dr. Spencer Nadolsky explains, is that some people \u201cmay respond to a low dose and not need a higher dose.\u201d In those cases, you wouldn\u2019t want to put someone on a \u201chigher dose, lose weight a lot faster and basically not be able to eat.\u201d In other words, faster isn\u2019t better, especially if it comes at the expense of feeling miserable.<\/p>\n
Providers look closely at both weight loss and side effects when making dosing decisions. In general, Dr. Nadolsky says clinicians aim for patients to lose \u201csomewhere around a half of a percent to one percent of their total body weight per week.\u201d If weight loss is slower than that, \u201cwe go up,\u201d he says.<\/p>\n
However, side effects take priority: \u201cIf they\u2019re having side effects, that takes the cake over everything else,\u201d he says. In those cases, providers may \u201ckeep them at the same dose.\u201d Dr. Salas-Whalen echoes the same idea. \u201cI look at appetite control, weight trends, side effects, energy levels, muscle preservation and overall well-being. If someone is losing weight appropriately, feeling well and eating adequately, there\u2019s often no need to increase the dose,\u201d she says.<\/p>\n
The goal for many patients is reaching a maintenance dose, which Dr. Salas-Whalen defines as the \u201clowest dose that allows someone to maintain their weight and metabolic health without unwanted side effects. You know you\u2019ve reached it when weight stabilizes, hunger is manageable, labs are stable and the patient feels physically and mentally well.\u201d<\/p>\n
As Drs. Nadolsky and Salas-Whalen explain, starting doses vary by medication. Below is a look at how dosing progresses across the most commonly used GLP-1 medications in weight-loss care. Some may be used off-label, depending on the medication and individual treatment plan.<\/p>\n
Tirzepatide, the active ingredient in the brand-name injectable GLP-1 medications Mounjaro and Zepbound, starts at 2.5 mg weekly and can be increased to 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg.<\/p>\n
Injectable semaglutide (Wegovy) starts at 0.25 mg weekly. The dose is then gradually increased to 0.5 mg, 1.0 mg, 1.7 mg and 2.4 mg. As Dr. Nadolsky notes, a higher 7.2 mg dose may be released in the future.<\/p>\n
Oral semaglutide starts at 1.5 mg daily and is gradually increased to 4 mg, 9 mg and 25 mg. Unlike injectable semaglutide for weight management, the oral version does not yet have a brand name. The only branded oral semaglutide\u2014Rybelsus\u2014is approved for type 2 diabetes.<\/p>\n<\/p><\/div>\n